rethinkPeptides Search
Menu
Research citation

Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer.

Acta pharmacologica Sinica, 46(12), 3291-3301

Citation

Bo, Qing; Zhang, Meng-Ge; Yang, Fan; Zheng, Yong; Li, Ze-Lin; Zheng, Yan-Min; Wu, Fang-Ming; Liang, Jun; Zhou, Li; Li, Dong-Sheng; Wu, Yun; Tian, Chang-Lin; Lv, Pei; Shi, Pan. (2025). Somatostatin receptor 2 targeting peptide modifications for peptide-drug conjugate treatment of small cell lung cancer.. Acta pharmacologica Sinica, 46(12), 3291-3301. https://doi.org/10.1038/s41401-025-01584-w